In addition, kallikrein has been shown to activate one of the collagenases in RA patient synovial fluid (52), and collagen is one of the common autoantigens and targets of destruction in RA (53) and is used in RA models as a stimulating antigen that can induce the disease. Here, KLK4 is linked to rheumatoid arthritis.